Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2007 08:05 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2006 Financial Results

CHARLOTTE, N.C., March 7, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will release fourth quarter and full year results for the period ended...
February 07, 2007 07:25 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Elects Kevan Clemens, Ph.D., as Chairman of the Board

CHARLOTTE, N.C., Feb. 7, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced today that its Board of Directors elected Kevan Clemens, Ph.D., Chairman of the Board...
February 01, 2007 07:35 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports Improved Pharmacokinetics of Its Disodium Salt of CH-1504

CHARLOTTE, N.C., Feb. 1, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) reported results from a recent primate study indicating that the new disodium salt of its lead...
January 22, 2007 07:25 ET | Source: Chelsea Therapeutics

FDA Grants Chelsea Therapeutics Orphan Drug Designation for Droxidopa

CHARLOTTE, N.C., Jan. 22, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug...
January 11, 2007 08:00 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Announces Results of European Phase IIb Trial of Droxidopa

CHARLOTTE, N.C., Jan. 11, 2007 (PRIME NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) reported the preliminary results of a European Phase IIb trial of Droxidopa, an orally...
November 14, 2006 08:05 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Reports Third Quarter 2006 Results

CHARLOTTE, N.C., Nov. 14, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today presented a quarterly update on the Company's development progress, reported financial...
November 02, 2006 08:15 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at the Rodman & Renshaw 8th Annual Global Healthcare Conference

CHARLOTTE, N.C., Nov. 2, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the Rodman & Renshaw 8th Annual Global Healthcare Conference at 3:10...
October 24, 2006 08:15 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at C.E. Unterberg, Towbin Life Sciences Conference

CHARLOTTE, N.C., Oct. 24, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the C.E. Unterberg, Towbin Life Sciences Conference at 11:00 AM ET on...
October 13, 2006 08:15 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics to Present at BIO Investor Forum

CHARLOTTE, N.C., Oct. 13, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the BIO Investor Forum Conference 2006. Chelsea's management will...
September 07, 2006 08:30 ET | Source: Chelsea Therapeutics

Chelsea Therapeutics Files Orphan Drug Application and Forms Scientific Advisory Board for Droxidopa

CHARLOTTE, N.C., Sept. 7, 2006 (PRIMEZONE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) has filed its application for Orphan Drug designation with the U.S. FDA and established a...